INTERCEPT aims to promote self-management and support patients with CHD to achieve a healthy lifestyle, manage CVD risk factors, and improve adherence to cardioprotective medications. It includes an mHealth app, which integrates with a web-based health care professional (HCP) portal, a fitness wearable, and a blood pressure monitor. Responding to the need for early initiation of prevention after an index event, particularly given delays in patients accessing traditional (CR) programs, INTERCEPT is designed to be introduced to the patient at the time of their acute hospitalization and before discharge home. In this way, it provides a bridge to CR or an alternative for patients who choose not to join a CR program.

To optimise INTERCEPT and its impact in terms of improving the standards of secondary CVD care, the development of INTERCEPT has been guided by the Medical Research Council (MRC) guidelines for the development and evaluation of complex interventions.